
|
 |
Research
Novel Avian Influenza H7N3
Strain Outbreak, British Columbia
Martin Hirst,* Caroline R. Astell,*
Malachi Griffith,* Shaun M. Coughlin,* Michelle Moksa,* Thomas Zeng,*
Duane E. Smailus,* Robert A. Holt,* Steven Jones,* Marco A. Marra,* Martin
Petric,† Mel Krajden,† David Lawrence,† Annie Mak,† Ron Chow,† Danuta
M. Skowronski,† S. Aleina Tweed,† SweeHan Goh,† Robert C. Brunham,† John
Robinson,‡ Victoria Bowes,‡Ken Sojonky,‡ Sean K. Byrne,‡ Yan Li,§ Darwyn
Kobasa,§ Tim Booth,§ and Mark Paetzel¶
*British Columbia Cancer Agency (BCCA) Genome Sciences Centre, Vancouver,
British Columbia, Canada; †British Columbia Centre for Disease Control
and University of British Columbia Centre for Disease Control, Vancouver,
British Columbia, Canada; ‡Ministry of Agriculture, Abbotsford, British
Columbia, Canada; §Canadian Centre for Human and Animal Health, Winnipeg,
Manitoba, Canada; and ¶Simon Fraser University, Burnaby, British Columbia,
Canada
Appendix
Materials and Methods
Growth of Avian Influenza
in Embryonated Chicken Eggs and Cell Culture
The tissue samples were homogenized in 10 volumes of virus isolation
diluent (peptone 10 g/L, gelatin 2.5 g/L, phosphate-buffered saline pH
7.4, gentamicin 100 mg/L, amphotericin B 5 mg/L, cyclohexamide 10 mg/L
). The homogenate was centrifuged twice at 3,000 x g for 30 min
to remove debris, and 0.2 mL of supernatant was injected into four 9-
to 11-day-old embryonated eggs obtained from a cloistered nonvaccinated
flock. Controls were injected with virus isolation fluid. Eggs were incubated
at 37°C and assessed for viability at 24 h. At 48 h, the eggs were
cooled, and the allantoic fluid was harvested. A hemagglutination test
was run using 0.5% chicken red blood cells, and hemagglutinin-positive
samples were confirmed by polymerase chain reaction (PCR). Nasopharyngeal
and conjunctival swab specimens from affected patients were injected into
primary rhesus monkey kidney cells and passaged further in Madin Darby
canine kidney cells (Diagnostic Hybrids, Athens, OH). The isolated viruses
were shown to be influenza A H7 by RT (reverse transcription)-PCR of the
RNA (1) and subsequently typed as H7N3 (National Microbiology
Laboratory, Winnipeg, MB, Canada).
RNA Extraction and RT-PCR
Trizol (Invitrogen, Burlington, ON, Canada) was used to extract vRNA
from 100 μL of allantoic fluid from infected embryonated eggs or 1
mL of infected Madin-Darby kidney cell culture. The vRNA was isolated
by using Phase Lock Gel, heavy 2 mL Eppendorf tubes (Brinkmann, Mississauga,
ON, Canada) according to the manufacturer's recommended protocol. RNA
was precipitated in 0.5 volumes of isopropanol in the presence of 0.2
mg of mussel glycogen (Invitrogen, Burlington, ON, Canada). The resulting
pellet was washed in 75% ethanol and resuspended in 40 μL of diethylpyrocarbonate-treated
dH20. A two step RT-PCR was used to amplify each of the viral
gene segments. The RNA (6 μL) was synthesized into cDNA by using 500
ng of Uni12 primer (Appendix Table) and the Powerscript
Reverse Transcriptase (BD Biosciences, Mississauga, ON), according to
the manufacturer's recommended protocol. The RT reaction was performed
at 42°C for 60 min. The cDNA was amplified by using the Expand Long
Template PCR System (Roche Diagnostics, Laval, QB, Canada), following
the protocol provided. The Mg2+ concentration was 3.5 mM, the
primer concentration was 0.4 mmol/L, and betaine was added to a final
concentration of 1 mol/L. Segment-specific primers were based on the universal
influenza A primer set designed by Hoffman et al. (2).
The cycling conditions consisted of an initial denaturation at 95oC
for 5 min followed by 10 touchdown PCR cycles starting with 95°C for
15 s, 68oC (decreased by 1oC in each subsequent
cycle) for 15 s, 68°C for 3 min; then 20 cycles of 95°C for 15
s, 62°C for 15 s, 68°C for 3 min; followed by an extension at
68°C for 10 min.
Isolation and Cloning of vRNA
Gene Segments
Ten microliters of the PCR reaction for each sample was loaded on an
1% agarose gel. The gel was stained with >SYBR Green (Mandel, Guelph,
ON, Canada) and visualized using a Typhoon 9400 Variable Mode Imager (Amersham,
Baie d'Urfe, QB, Canada). Visible bands of expected size were excised
from the agarose gel, and purified using the MinElute Gel Extraction Kit
(Qiagen, Mississauga, ON) following the manufacturer's protocol. Purified
amplicons were cloned into the pCR4-TOPO vector by using the TOPO TA Cloning
Kit for Sequencing (Invitrogen), according to the manufacturer's protocol.
vRNA gene Segment Sequencing
Eight clone inserts for each genomic segment were randomly selected and
sequenced on an ABI PRISM 3730 XL DNA Analyzer with BigDye v3.1 primer
cycle sequencing reagents (Applied Biosystems Canada, Streetsville, ON,
Canada). End reads were obtained by using T3 and T7 reverse primers. Sequence
reads were processed, and their quality was assessed by using Phred
and assembled by using Phrap (3,4). When needed,
specific sequencing primers were designed by manual selection from primer
sequences generated by Consed (5), and full-length sequences
were obtained by primer walking.
The Appendix Table gives a comparison of individual
gene segments of the Fraser Valley H7N3 outbreak with influenza genes
from GenBank showing the highest similarity. Appendix
Figure 1 provides complete nucleotide and protein alignments for the
HA gene for the five isolates sequences in this study, and Appendix
Figure 2 is a phylogenetic tree of isolates described in the text.
Homology Modeling
The 0.28-nm resolution crystal structure of the hemagglutinin precursor
protein from influenza A virus, human H3, strain CV-1 (PDB code HA01)
was used as the template (6). An initial sequence alignment
was performed with the program ClustalW (7) and then
modified by hand, resulting in 49.9 % sequence identity (Appendix
Figure 3). The initial model was made by using the program O (8)
and then energy minimized with the program CNS (9). The
monomer model was superimposed onto the trimeric 1HA0 template structure
by using the program superimpose (10) and then further
energy minimized by using CNS. The model includes residues 21 through
519 (lacking the N-terminal 20 residues and the C-terminal 48 residues)
of the human A/Canada/504/04 (Hu504) hemagglutinin precursor. The figures
were prepared by using the program PyMol (11).
Appendix
References
- Spackman E, Senne DA, Myers TJ, Bulaga LL, Garber
LP, et al. Development
of a real-time reverse transcriptase PCR assay for type A influenza
virus and the avian H5 and H7 hemagglutinin subtypes. J Clin Microbiol.
2002;40:3256–60.
- Hoffmann E, Stech J, Guan Y, Webster RG, Perez DR. Universal
primer set for the full-length amplification of all influenza viruses.
Arch Virol. 2001;146:2275–80.
- Ewing B, Green P. Base-calling
of automated sequencer traces using phred. II. Error probabilities.
Genome Res. 1998;8:186–94.
- Ewing B, Hillier L, Wendl MC, Green P. Base-calling
of automated sequencer traces using phred. I. Accuracy assessment.
Genome Res. 1998;8:175–85.
- Gordon D, Abajian C, Green P. Consed:
a graphical tool for sequence finishing. Genome Res. 1998;8:195–202.
- Chen J, Lee KH, Steinhauer DA, Stevens DJ, Skehel JJ, Wiley DC. Structure
of the hemagglutinin precursor cleavage site, a determinant of influenza
pathogenicity and the origin of the labile conformation. Cell. 1998;95:409–17.
- Thompson JD, Higgins DG, Gibson TJ. CLUSTAL
W: improving the sensitivity of progressive multiple sequence alignment
through sequence weighting, position-specific gap penalties and weight
matrix choice. Nucleic Acids Res. 1994;22:4673–80.
- Jones TA, Zou JY, Cowan SW, Kjelgaard M. Improved
methods for building protein models in electron density maps and the
location of errors in these models. Acta Crystallogr A. 1991;47:110–9.
- Brunger AT, Adams PD, Clore GM, DeLano WL, Gros P, et al. Crystallography
and NMR system: a new software suite for macromolecular structure determination.
Acta Crystallogr D Biol Crystallogr. 1998;54:905–21.
- Diederichs K. Structural
superposition of proteins with unknown alignment and detection of topological
similarity using a six-dimensional search algorithm. Proteins. 1995;23:187–95.
- DeLano WL. The PyMOL user's manual. San Carlos (CA):
DeLano Scientific, USA; 2002. Available from http://www.pymol.org
| Appendix
Table. Comparison of individual gene segments of four isolates
of the Fraser Valley H7N3 outbreak in 2004 with full length influenza
genes from GenBank showing the highest similaritya |
|
|
Query accession no.
|
Isolate name
|
Length (bp)
|
BLASTN identity (%)
|
Accession no. and isolate name
|
BLASTP identity (%)
|
Accession no. and isolate name
|
|
|
AY650270
|
A/Chicken/Canada/AVFV1/04 HA
|
1,733
|
95
|
AF072384 A/Chicken/NewYork/13142-5/94 (H7N3)
|
97
|
AAD26923 A/Chicken/NewYork/13142-5/94 (H7N3)
|
|
AY648287
|
A/Chicken/Canada/AVFV2/04 HA
|
1,754
|
96
|
AF072384 A/Chicken/NewYork/13142-5/94 (H7N3)
|
96
|
AAD26923 A/Chicken/NewYork/13142-5/94 (H7N3)
|
|
AY611524
|
A/Canada/444/04 (human) HA
|
1,754
|
96
|
AF072384 A/Chicken/NewYork/13142-5/94 (H7N3)
|
96
|
AAD26923 A/Chicken/NewYork/13142-5/94 (H7N3)
|
|
AY646078
|
A/Canada/504/04 (human) HA
|
1,754
|
96
|
AF072384 A/Chicken/NewYork/13142-5/94 (H7N3)
|
96
|
AAD26923 A/Chicken/NewYork/13142-5/94 (H7N3)
|
|
AY650271
|
A/Chicken/Canada/AVFV1/04 M
|
1,027
|
98
|
AF073198 A/Turkey/Colorado/13356/91(H7N3NSA)
|
100
(M1)
|
AAB19773 A/Turkey/Minnesota/833/80 (H4N2)
|
|
100
(M2)
|
AAQ77433 A/Chicken/Chile/176822/02 (H7N3)
|
|
AY648288
|
A/Chicken/Canada/AVFV2/04 M
|
1,027
|
98
|
AF073198 A/Turkey/Colorado/13356/91(H7N3NSA)
|
100
(M1)
|
AAB19773
|
|
100
(M2)
|
AAQ77433
|
|
AY611525
|
A/Canada/444/04 (human) M
|
1,027
|
98
|
AF073198 A/Turkey/Colorado/13356/91(H7N3NSA)
|
100
(M1)
|
AAB19773
|
|
100
(M2)
|
AAQ77433
|
|
AY646079
|
A/Canada/504/04 (human) M
|
1,027
|
98
|
AF073198 A/Turkey/Colorado/13356/91(H7N3NSA)
|
100
(M1)
|
AAB19773
|
|
100
(M2)
|
AAQ77433
|
|
AY650272
|
A/Chicken/Canada/AVFV1/04 NA
|
1,453
|
97
|
AY300951 A/blue-winged teal/TX/2/01 (H7N3)
|
98
|
AAP57563 A/blue-winged teal/TX/2/01 (H7N3)
|
|
AY648289
|
A/Chicken/Canada/AVFV2/04 NA
|
1,453
|
98
|
AY300951 A/blue-winged teal/TX/2/01 (H7N3)
|
98
|
"
|
|
AY611526
|
A/Canada/444/04 (human) NA
|
1,453
|
97
|
AY300951 A/blue-winged teal/TX/2/01 (H7N3)
|
97
|
"
|
|
AY646080
|
A/Canada/504/04 (human) NA
|
1,453
|
98
|
AY300951 A/blue-winged teal/TX/2/01 (H7N3)
|
98
|
"
|
|
AY650273
|
A/Chicken/Canada/AVFV1/04 NP
|
1,565
|
95
|
M30766 A/ruddyturnstone/NewJersey/47/85 (H4N6)
|
100
|
AAG17432 A/Swine/Ontario/)1911-1/99 (H4N6)
|
|
AY648290
|
A/Chicken/Canada/AVFV2/04 NP
|
1,565
|
95%
|
M30766 A/ruddyturnstone/NewJersey/47/85 (H4N6)
|
99
|
"
|
|
AY611527
|
A/Canada/444/04 (human) NP
|
1,565
|
95%
|
M30766 A/ruddyturnstone/NewJersey/47/85 (H4N6)
|
99
|
"
|
|
AY646081
|
A/Canada/504/04 (human) NP
|
1,565
|
95%
|
M30766 A/ruddyturnstone/NewJersey/47/85 (H4N6)
|
99
|
"
|
|
AY650274
|
A/Chicken/Canada/AVFV1/04 NS
|
890
|
98%
|
U85391 A/Turkey/Minnesota/10734/95
|
99
(NS1)
|
AAA43130 A/Anas acuta/Primrje/695/76 (H3N2)
|
|
99
(NS2)
|
AAK14369 A/Brevig-Mission/1/18 (H1N1)
|
|
AY648291
|
A/Chicken/Canada/AVFV2/04 NS
|
890
|
98
|
U85391 A/Turkey/Minnesota/10734/95
|
99
(NS1)
|
AAA43130
|
|
99
(NS2)
|
AAK14369
|
|
AY611528
|
A/Canada/444/04 (human) NS
|
890
|
98
|
U85391 A/Turkey/Minnesota/10734/95
|
99
(NS1)
|
AAA43130
|
|
99
(NS2)
|
AAK14369
|
|
AY646082
|
A/Canada/504/04 (human) NS
|
890
|
98
|
U85391 A/Turkey/Minnesota/10734/95
|
99
(NS1)
|
AAA43130
|
|
AY650275
|
A/Chicken/Canada/AVFV1/04 PA
|
2,230
|
94
|
AF285890 A/Swine/Ontario/01011-1/99 (H4N6)
|
98
|
CAB56290 A/Mallard.NewYork/6750/78
|
|
AY648292
|
A/Chicken/Canada/AVFV2/04 PA
|
2,233
|
95
|
AF285890 A/Swine/Ontario/01011-1/99 (H4N6)
|
98
|
CAB56290 A/Mallard.NewYork/6750/78
|
|
AY616764
|
A/Canada/444/04 (human) PA
|
2,233
|
95
|
AF285890 A/Swine/Ontario/01011-1/99 (H4N6)
|
98
|
CAB56290 A/Mallard.NewYork/6750/78
|
|
AY646083
|
A/Canada/504/04 (human) PA
|
2,233
|
95
|
AF285890 A/Swine/Ontario/01011-1/99 (H4N6)
|
98
|
CAB56290 A/Mallard.NewYork/6750/78
|
|
AY653039
|
A/Chicken/Canada/AVFV1/04 PB1
|
2,341
|
95
|
M25925 A/Turkey/Minnesota/833/80 (H4N2)
|
99
|
AAG17436 A/Swine/Ontarion/01911-1/99 (H4N6)
|
|
AY648293
|
A/Chicken/Canada/AVFV2/04 PB1
|
2,341
|
95
|
M25925 A/Turkey/Minnesota/833/80 (H4N2)
|
99
|
AAG17436 A/Swine/Ontarion/01911-1/99 (H4N6)
|
|
AY616765
|
A/Canada/444/04 (human) PB1
|
2,341
|
95
|
M25925 A/Turkey/Minnesota/833/80 (H4N2)
|
98
|
AAG17436 A/Swine/Ontarion/01911-1/99 (H4N6)
|
|
AY646084
|
A/Canada/504/04 (human) PB1
|
2,341
|
95
|
M25925 A/Turkey/Minnesota/833/80 (H4N2)
|
99
|
AAG17436 A/Swine/Ontarion/01911-1/99 (H4N6)
|
|
AY650276
|
A/Chicken/Canada/AVFV1/04 PB2
|
2,341
|
93
|
M73522 A/Seal/Massachusetts/133/82 (H4N5)
|
99
|
AAR04359 A/Chicken/Netherlands/1/03 (H7N7)
|
|
AY648294
|
A/Chicken/Canada/AVFV2/04 PB2
|
2,341
|
93
|
M73522 A/Seal/Massachusetts/133/82 (H4N5)
|
99
|
AAR04359 A/Chicken/Netherlands/1/03 (H7N7)
|
|
AY616766
|
A/Canada/444/04 (human) PB2
|
2,341
|
93
|
M73522 A/Seal/Massachusetts/133/82 (H4N5)
|
99
|
AAR04359 A/Chicken/Netherlands/1/03 (H7N7)
|
|
AY646085
|
A/Canada/504/04 (human) PB2
|
2,341
|
93
|
M73522 A/Seal/Massachusetts/133/82 (H4N5)
|
99
|
AAR04359 A/Chicken/Netherlands/1/03 (H7N7)
|
|
| aQuery accession
no., isolate name and length (bp); GenBank accession no., isolate
name, and nucleotide length for each gene segment, respectively; BLASTN
identity, percentage of identical nucleotides as assigned by BLASTN;
accession no., GenBank nucleotide accession no., and isolate name;
BLASTP identity, percentage of identical nucleotides as assigned by
BLASTP; accession no., GenBank protein accession no., and isolate
name. |
|